GENE ONLINE|News &
Opinion
Blog

LATEST
Ablaze Pharma Launches with $75 Million to Bring Targeted Radiotherapies into China
2021-12-01
After Raising $300 Million, China’s Abogen Hunkers Down on mRNA Covid-19 Vaccine with GenScript and Walvax
2021-12-01
Bioplus Interphex 2021: CDMOs- The Manufacturing Hub for the Next Generation of Therapeutics
2021-11-30
Harnessing the potential of CRISPR-Cas9 for Gut Microbiome Gene Editing
2021-11-29
Samsung Biologics Strikes Deal with GreenLight Bio to Manufacture mRNA Vaccines
2021-11-29
Brukinsa Receives EU Approval for the Treatment of Rare Lymphoma
2021-11-27
Roche Gets Shareholders Nod to Repurchase $21B Equity Stake Held By Novartis
2021-11-27
Starpharma Announces Encouraging Interim Results for Prostate Cancer Drug
2021-11-27
Updated Trial Data Shows Lower Efficacy for Merck’s Oral COVID-19 Pill
2021-11-26
Heavily Mutated COVID-19 Variant Emerges in South Africa, Sparks Concerns
2021-11-26
Cancer Cells Build Nano-Highways to Hijack Mitochondria from Immune Cells
2021-11-25
FDA Places Clinical Hold on Kura Oncology’s Acute Myeloid Leukemia Therapeutic
2021-11-25
China’s Neurophth Snags $63 Million in Series C to Boost Ophthalmic Gene Therapy Portfolio
2021-11-25
Breakthrough Cryo-EM Study Reveals How Viral RNA Hijacks Host Machinery
2021-11-24
Takeda’s Livtencity Bags FDA Approval for the Treatment of Post-Transplant Infection
2021-11-24
1 106 107 108 109 110 218
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top